EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:EVH - US30050B1017 - Common Stock
4.02 USD
+0.03 (+0.75%)
3.98 USD
-0.04 (-1%)
Taking everything into account, EVH scores 2 out of 10 in our fundamental rating. EVH was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of EVH have multiple concerns. While showing a medium growth rate, EVH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
EVH had negative earnings in the past year.
In the past year EVH has reported a negative cash flow from operations.
In the past 5 years EVH always reported negative net income.
In multiple years EVH reported negative operating cash flow during the last 5 years.
1.2 Ratios
EVH's Return On Assets of -7.37% is fine compared to the rest of the industry. EVH outperforms 62.86% of its industry peers.
Looking at the Return On Equity, with a value of -21.48%, EVH is in line with its industry, outperforming 60.00% of the companies in the same industry.
EVH's Return On Invested Capital of 0.68% is in line compared to the rest of the industry. EVH outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROIC | 0.68% |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EVH's Operating Margin of 0.86% is fine compared to the rest of the industry. EVH outperforms 65.71% of its industry peers.
The Gross Margin of EVH (18.42%) is worse than 82.86% of its industry peers.
In the last couple of years the Gross Margin of EVH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EVH is destroying value.
Compared to 1 year ago, EVH has more shares outstanding
Compared to 5 years ago, EVH has more shares outstanding
EVH has a worse debt/assets ratio than last year.
2.2 Solvency
EVH has an Altman-Z score of 0.59. This is a bad value and indicates that EVH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.59, EVH perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
A Debt/Equity ratio of 1.26 is on the high side and indicates that EVH has dependencies on debt financing.
The Debt to Equity ratio of EVH (1.26) is worse than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.59 |
ROIC/WACC0.09
WACC8.04%
2.3 Liquidity
EVH has a Current Ratio of 1.33. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
EVH has a Current ratio of 1.33. This is in the lower half of the industry: EVH underperforms 65.71% of its industry peers.
EVH has a Quick Ratio of 1.33. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.33, EVH is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.10%.
The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
Looking at the last year, EVH shows a very negative growth in Revenue. The Revenue has decreased by -16.65% in the last year.
The Revenue has been growing by 30.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
3.2 Future
The Earnings Per Share is expected to grow by 8.00% on average over the next years.
EVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.63% yearly.
EPS Next Y-85.65%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue Next Year-26.69%
Revenue Next 2Y-2.92%
Revenue Next 3Y2.38%
Revenue Next 5Y6.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EVH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 11.40, the valuation of EVH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, EVH is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
EVH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.4 |
4.2 Price Multiples
EVH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EVH is cheaper than 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.75 |
4.3 Compensation for Growth
A cheap valuation may be justified as EVH's earnings are expected to decrease with -7.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
5. Dividend
5.1 Amount
EVH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
4.02
+0.03 (+0.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners123.68%
Inst Owner Change6.57%
Ins Owners1.62%
Ins Owner Change1.11%
Market Cap448.63M
Revenue(TTM)2.05B
Net Income(TTM)-180.88M
Analysts85.26
Price Target10.38 (158.21%)
Short Float %16.54%
Short Ratio4.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.54%
Min EPS beat(2)-226.45%
Max EPS beat(2)-52.63%
EPS beat(4)0
Avg EPS beat(4)-162.45%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)3
Avg EPS beat(8)-78.52%
EPS beat(12)6
Avg EPS beat(12)-25.77%
EPS beat(16)10
Avg EPS beat(16)442.42%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)1.03%
PT rev (1m)-35.03%
PT rev (3m)-35.03%
EPS NQ rev (1m)-32.39%
EPS NQ rev (3m)-53.28%
EPS NY rev (1m)-61.89%
EPS NY rev (3m)-64.46%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.4 | ||
| P/S | 0.22 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.75 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.35
Fwd EY8.77%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS18.41
BVpS7.55
TBVpS-7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROCE | 0.87% | ||
| ROIC | 0.68% | ||
| ROICexc | 0.73% | ||
| ROICexgc | 6.52% | ||
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% | ||
| FCFM | N/A |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score4
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.01 | ||
| Cap/Depr | 32.44% | ||
| Cap/Sales | 1.58% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 0.59 |
F-Score4
WACC8.04%
ROIC/WACC0.09
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-85.65%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
Revenue Next Year-26.69%
Revenue Next 2Y-2.92%
Revenue Next 3Y2.38%
Revenue Next 5Y6.63%
EBIT growth 1Y218.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.61%
EBIT Next 3Y71.11%
EBIT Next 5Y48.15%
FCF growth 1Y-223.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.71%
OCF growth 3Y-21.47%
OCF growth 5YN/A
EVOLENT HEALTH INC - A / EVH FAQ
What is the fundamental rating for EVH stock?
ChartMill assigns a fundamental rating of 2 / 10 to EVH.
What is the valuation status for EVH stock?
ChartMill assigns a valuation rating of 3 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.
Can you provide the profitability details for EVOLENT HEALTH INC - A?
EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.
What is the financial health of EVOLENT HEALTH INC - A (EVH) stock?
The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.